The histone deacetylase inhibitor NVP-LAQ824 Inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
David Z. Qian, Xiaofei Wang, Sushant K. Kachhap, Yukihiko Kato, Yongfeng Wei, Lu Zhang, Peter Atadja, Roberto Pili
Dive into the research topics of 'The histone deacetylase inhibitor NVP-LAQ824 Inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584'. Together they form a unique fingerprint.